Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ernexa Therapeutics Inc.
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
May 10, 2026
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
May 9, 2026
Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
May 5, 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
April 29, 2026
←
Previous Page
1
2